• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化中的机会性病原体:肺部感染的流行病学和发病机制。

Opportunistic Pathogens in Cystic Fibrosis: Epidemiology and Pathogenesis of Lung Infection.

机构信息

Department of Pediatrics, Division of Infectious Diseases, CHU Sainte-Justine, Université de Montréal, 3175 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1C5, Canada.

Department of Pediatrics, Division of Infectious Diseases, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada.

出版信息

J Pediatric Infect Dis Soc. 2022 Sep 7;11(Supplement_2):S3-S12. doi: 10.1093/jpids/piac052.

DOI:10.1093/jpids/piac052
PMID:36069904
Abstract

Cystic fibrosis (CF) is one of the most common life-shortening genetic diseases in Caucasians. Due to abnormal accumulation of mucus, respiratory failure caused by chronic infections is the leading cause of mortality in this patient population. The microbiology of these respiratory infections includes a distinct set of opportunistic pathogens, including Pseudomonas aeruginosa, Burkholderia spp., Achromobacter spp., Stenotrophomonas maltophilia, anaerobes, nontuberculous mycobacteria, and fungi. In recent years, culture-independent methods have shown the polymicrobial nature of lung infections, and the dynamics of microbial communities. The unique environment of the CF airway predisposes to infections caused by opportunistic pathogens. In this review, we will highlight how the epidemiology and role in disease of these pathogens in CF differ from that in individuals with other medical conditions. Infectious diseases (ID) physicians should be aware of these differences and the specific characteristics of infections associated with CF.

摘要

囊性纤维化 (CF) 是白种人中最常见的缩短寿命的遗传疾病之一。由于粘液异常积聚,慢性感染导致的呼吸衰竭是该患者人群死亡的主要原因。这些呼吸道感染的微生物学包括一组独特的机会性病原体,包括铜绿假单胞菌、伯克霍尔德菌属、不动杆菌属、嗜麦芽窄食单胞菌、厌氧菌、非结核分枝杆菌和真菌。近年来,非培养方法显示了肺部感染的多微生物性质和微生物群落的动态变化。CF 气道的独特环境易发生机会性病原体感染。在这篇综述中,我们将重点介绍这些病原体在 CF 中的流行病学和疾病作用如何与其他疾病患者中的情况有所不同。传染病 (ID) 医生应该了解这些差异以及与 CF 相关感染的具体特征。

相似文献

1
Opportunistic Pathogens in Cystic Fibrosis: Epidemiology and Pathogenesis of Lung Infection.囊性纤维化中的机会性病原体:肺部感染的流行病学和发病机制。
J Pediatric Infect Dis Soc. 2022 Sep 7;11(Supplement_2):S3-S12. doi: 10.1093/jpids/piac052.
2
The cystic fibrosis lung microbiome.囊性纤维化肺部微生物群。
Ann Am Thorac Soc. 2014 Jan;11 Suppl 1:S61-5. doi: 10.1513/AnnalsATS.201306-159MG.
3
Pathophysiology and management of pulmonary infections in cystic fibrosis.囊性纤维化肺部感染的病理生理学与管理
Am J Respir Crit Care Med. 2003 Oct 15;168(8):918-51. doi: 10.1164/rccm.200304-505SO.
4
The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.囊性纤维化和非囊性纤维化支气管扩张中的微生物群与新出现的病原体
Semin Respir Crit Care Med. 2015 Apr;36(2):225-35. doi: 10.1055/s-0035-1546752. Epub 2015 Mar 31.
5
[Emerging bacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis from a microbiologist's perspective].从微生物学家角度看囊性纤维化和非囊性纤维化支气管扩张症中的新兴细菌
Rev Mal Respir. 2020 Sep;37(7):561-571. doi: 10.1016/j.rmr.2020.06.006. Epub 2020 Jul 16.
6
Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.囊性纤维化病原体嗜麦芽窄食单胞菌在痰液中的反硝化作用处于休眠状态。
Int J Med Microbiol. 2015 Jan;305(1):1-10. doi: 10.1016/j.ijmm.2014.07.002. Epub 2014 Aug 10.
7
Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis center.研究法国囊性纤维化中心嗜麦芽寡养单胞菌的流行病学。
Respir Med Res. 2020 Nov;78:100757. doi: 10.1016/j.resmer.2020.100757. Epub 2020 Apr 18.
8
Pseudomonas aeruginosa Promotes Persistence of Stenotrophomonas maltophilia via Increased Adherence to Depolarized Respiratory Epithelium.铜绿假单胞菌通过增加对去极化呼吸上皮的黏附促进嗜麦芽寡养单胞菌的持久性。
Microbiol Spectr. 2023 Feb 14;11(1):e0384622. doi: 10.1128/spectrum.03846-22. Epub 2022 Dec 6.
9
Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis-data from the European cystic fibrosis society patient registry.囊性纤维化患者呼吸道细菌学的流行病学变化:来自欧洲囊性纤维化协会患者登记处的数据。
J Cyst Fibros. 2020 May;19(3):376-383. doi: 10.1016/j.jcf.2019.08.006. Epub 2019 Sep 3.
10
Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.患有囊性纤维化的幼儿呼吸道细菌病原体感染的季节性
BMC Infect Dis. 2017 Jun 9;17(1):411. doi: 10.1186/s12879-017-2511-9.

引用本文的文献

1
In Vitro Activity of Cefiderocol and Aztreonam/Avibactam Against Gram-Negative Non-Fermenting Bacteria: A New Strategy Against Highly Antibiotic-Resistant Infectious Agents.头孢地尔和氨曲南/阿维巴坦对革兰氏阴性非发酵菌的体外活性:对抗高度耐药感染病原体的新策略
Antibiotics (Basel). 2025 Jul 29;14(8):762. doi: 10.3390/antibiotics14080762.
2
Cross-membrane cooperation among bacteria can facilitate intracellular pathogenesis.细菌之间的跨膜合作可促进细胞内致病作用。
Nat Commun. 2025 Aug 11;16(1):7419. doi: 10.1038/s41467-025-62575-3.
3
Mechanisms of Lung Cancer Development in Cystic Fibrosis Patients: The Role of Inflammation, Oxidative Stress, and Lung Microbiome Dysbiosis.
囊性纤维化患者肺癌发生的机制:炎症、氧化应激和肺部微生物群失调的作用
Biomolecules. 2025 Jun 6;15(6):828. doi: 10.3390/biom15060828.
4
Harnessing hypoxia: bacterial adaptation and chronic infection in cystic fibrosis.利用缺氧:囊性纤维化中的细菌适应与慢性感染
FEMS Microbiol Rev. 2025 Jan 14;49. doi: 10.1093/femsre/fuaf018.
5
Heterogeneity in recombination rates and accessory gene co-occurrence distinguish phylogroups.重组率和辅助基因共现的异质性区分了系统发育群。
mSystems. 2025 May 20;10(5):e0030125. doi: 10.1128/msystems.00301-25. Epub 2025 Apr 30.
6
Efficacy of Adding Oral N acetyl Cysteine Supplement to the Cystic Fibrosis Treatment Regimen: A Randomized Quasi-Experimental Trial.在囊性纤维化治疗方案中添加口服N-乙酰半胱氨酸补充剂的疗效:一项随机准实验性试验。
J Res Pharm Pract. 2025 Mar 11;13(3):72-77. doi: 10.4103/jrpp.jrpp_54_24. eCollection 2024 Jul-Sep.
7
and in dual-species models: Insights into population distribution, antibiotic susceptibility, and virulence.以及在双物种模型中:对种群分布、抗生素敏感性和毒力的见解。
Virulence. 2025 Dec;16(1):2494039. doi: 10.1080/21505594.2025.2494039. Epub 2025 Apr 24.
8
Achromobacter spp.: Emerging pathogens in the cystic fibrosis lung.无色杆菌属:囊性纤维化肺部的新兴病原体。
PLoS Pathog. 2025 Apr 22;21(4):e1013067. doi: 10.1371/journal.ppat.1013067. eCollection 2025 Apr.
9
Ginsenosides and gut microbiota: differential effects on healthy individuals and irritable bowel syndrome subtypes.人参皂苷与肠道微生物群:对健康个体和肠易激综合征亚型的不同影响。
PeerJ. 2025 Apr 15;13:e19223. doi: 10.7717/peerj.19223. eCollection 2025.
10
Improved Clinical Outcomes With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease: Real-World Evidence From an Italian Single-Center Study.依列卡福妥/替扎卡福妥/依伐卡托治疗囊性纤维化和晚期肺部疾病患者的临床结局改善:来自意大利单中心研究的真实世界证据
Pharmacol Res Perspect. 2025 Apr;13(2):e70083. doi: 10.1002/prp2.70083.